Rahlfs Capital’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$740K Sell
5,095
-230
-4% -$31.8K 0.49% 49
2026
Q2
$684K Hold
5,325
– – 0.5% 51
2026
Q1
$641K Hold
5,325
– – 0.47% 53
2025
Q4
$561K Hold
5,325
– – 0.44% 54
2025
Q3
$447K Hold
5,325
– – 0.35% 58
2025
Q2
$422K Hold
5,325
– – 0.39% 59
2025
Q1
$478K Hold
5,325
– – 0.48% 49
2024
Q4
$530K Buy
+5,325
New +$549K 0.52% 47

Other funds holding MRK

Rahlfs Capital's MRK Position: Q3 2026 in Review

Rahlfs Capital reduced its Merck (MRK) stake by 4.3% in Q3 2026, selling an estimated $31.8K and leaving 5,095 shares worth $740K. The position accounts for 0.49% of the portfolio, ranked #49.

Rahlfs Capital first reported a position in MRK in Q4 2024 and has held it in 8 quarters since. 3,070 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Rahlfs Capital held 5,095 shares of Merck worth $740K as of Q3 2026.
  • Rahlfs Capital sold 230 Merck shares in Q3 2026, an estimated $31.8K.
  • Merck made up 0.49% of Rahlfs Capital's portfolio in Q3 2026, its #49 holding.
  • Rahlfs Capital first reported a position in Merck in Q4 2024 and has held it in 8 quarters since.
  • 3,070 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Rahlfs Capital's 13F filing for Q3 2026, filed 23 Oct 2026.